Plerixafor solution

(Synonyms: AMD 3100 solution; JM3100 solution; SID791 solution)
103 Cited Publications
Revisión del cliente

Based on 103 publication(s) in Google Scholar

Plerixafor solution (AMD 3100 solution; JM3100 solution; SID791 solution) is a CXCR4 antagonist and a CXCR7 allosteric agonist; Plerixafor solution disrupts stem cell retention in the bone marrow by blocking the SDF-1α/CXCL12‑CXCR4 signaling pathway and inhibiting chemokine-mediated receptor internalization, mobilizing peripheral blood leukocytes, neutrophils, endothelial progenitor cells, and B cells; Plerixafor solution alleviates Silicon dioxide (HY-W019831)-induced pulmonary inflammation and fibrosis, inhibits corneal neovascularization and CXCL12-induced cell migration, and simultaneously suppresses ischemia-induced inflammatory responses, reduces blood-brain barrier permeability, attenuates cerebral edema, and reduces infarct volume. Plerixafor solution can be used in research related to liver fibrosis, silicosis, colorectal cancer, and ischemic stroke.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 110078-46-1
  • Fòrmula: C28H54N8
  • Peso molecular:502.78
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00